In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries

• Váldodahkkit: Tobias Manuel Appel (Dahkki), María Fernanda Mojica (Dahkki), Elsa De La Cadena (Dahkki), Christian José Pallares (Dahkki), Marcela A. Radice (Dahkki), Paulo Castañeda-Méndez (Dahkki), Diego A. Jaime-Villalón (Dahkki), Ana C. Gales (Dahkki), José M. Munita (Dahkki), María Virginia Villegas (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2020-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

<i>Background</i>: High rates of resistance to third-generation cephalosporins and carbapenems in Enterobacterales have been reported in Latin America. Ceftazidime/avibactam (CZA) is the combination of a third-generation cephalosporin and a non-β-lactam β-lactamase inhibitor, which has s...